Article

Quantum dot-containing polymer particles with thermosensitive fluorescence

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russian Federation.
Biosensors & Bioelectronics (Impact Factor: 6.41). 07/2012; 39(1):187-93. DOI: 10.1016/j.bios.2012.07.030
Source: PubMed

ABSTRACT

Composite polymer particles consisting of a solid poly(acrolein-co-styrene) core and a poly(N-vinylcaprolactam) (PVCL) polymer shell doped with CdSe/ZnS semiconductor quantum dots (QDs) were fabricated. The temperature response of the composite particles was observed as a decrease in their hydrodynamic diameter upon heating above the lower critical solution temperature of the thermosensitive PVCL polymer. Embedding QDs in the PVCL shell yields particles whose fluorescence is sensitive to temperature changes. This sensitivity was determined by the dependence of the QD fluorescence intensity on the distances between them in the PVCL shell, which reversibly change as a result of the temperature-driven conformational changes in the polymer. The QD-containing thermosensitive particles were assembled with protein molecules in such a way that they retained their thermosensitive properties, including the completely reversible temperature dependence of their fluorescence response. The composite particles developed can be used as local temperature sensors, as carriers for biomolecules, as well as in biosensing and various bioassays employing optical detection schemes.

Download full-text

Full-text

Available from: Alla N Generalova
  • [Show abstract] [Hide abstract]
    ABSTRACT: Many proteins benefit from improved solubility, immunocompatibility, pharmacokinetics or stability upon conjugation to polymers. For protein-conjugates used in delivery or imaging in vivo, this can mean increased efficacies due to longer circulatory half-lives or increased intracellular stability. In vitro, conjugation to polymers can increase stability, reduce aggregation, or mediate multimerization or phase separation of proteins to increase assay sensitivities or improve signal detection. The emergence of recombinant antibody technologies over the past two decades has allowed relatively simple isolation in vitro of (human) antibody fragments, such as Fabs and single chain variable fragments (scFvs), that retain the binding properties of their parent molecules and may exhibit additional properties such as reduced immunogenicity, improved tissue penetration or increased packing density on sensor surfaces due to their small sizes. In addition, protein engineering approaches that facilitate their chemical functionalization have seen antibody fragments linked to a broad spectrum of chemically and functionally diverse polymeric molecules. Of the varied strategies used in polymer–protein coupling, amine and cysteine conjugation are the most widely applied chemistries with antibody fragments. Simple conjugation to poly(ethyleneglycol) can increase half-life, decrease renal clearance, improve stability and reduce aggregation of antibody fragments without compromising their antigen binding. Meanwhile, engineering of antibody fragments can be used to control conjugation to polymers and coupling to responsive polymers can enable intracellular delivery or context responsive release of a drug payload from a polymer–antibody fragment complex. Recent years have seen polymer–antibody fragment conjugates increasingly encroach into areas traditionally associated with monoclonal antibody–polymers and we discuss the potential of such conjugates, in vivo and in vitro, in applications such as drug delivery, tissue engineering, diagnostics and bioseparation.
    No preview · Article · Jan 2013
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Due to threat coming from viral diseases, mainly from influenza, new assays and devices are investigated. This study is aimed at developing of low-cost isolation and detection of specific influenza protein hemagglutinin (HA) labelled with CdS, PbS, and CuS quantum dots. The influenza protein was determined via concentration of cadmium(II), lead(II), and copper(II) ions contained in quantum dots using stopped flow injection analysis with electrochemical detection (SFIA-ED). The main attention was devoted to detection of quantum dots and optimization of the whole analytical system. A particular aim was focused on an application of streptavidin-coated paramagnetic particles that were modified with biotinylated glycan. In addition, their selective binding properties to the influenza virus were monitored. Based on the results it can be concluded that CdS QDs were the best label for viral protein determination.
    Full-text · Article · Aug 2013 · International journal of electrochemical science
  • [Show abstract] [Hide abstract]
    ABSTRACT: Many proteins benefit from improved solubility, immunocompatibility, pharmacokinetics or stability upon conjugation to polymers. For protein-conjugates used in delivery or imaging in vivo, this can mean increased efficacies due to longer circulatory half-lives or increased intracellular stability. In vitro, conjugation to polymers can increase stability,reduce aggregation, or mediate multimerization or phase separation of proteins to increase assay sensitivities or improve signal detection. The emergence of recombinant antibody technologies over the past two decades has allowed relatively simple isolation in vitro of(human) antibody fragments, such as Fabs and single chain variable fragments (scFvs),that retain the binding properties of their parent molecules and may exhibit additional properties such as reduced immunogenicity, improved tissue penetration or increased packing density on sensor surfaces due to their small sizes. In addition, protein engineering approaches that facilitate their chemical functionalization have seen antibody fragments linked to a broad spectrum of chemically and functionally diverse polymeric molecules. Of the varied strategies used in polymer–protein coupling, amine and cysteine conjugation are the most widely applied chemistries with antibody fragments. Simple conjugation to poly(ethyleneglycol) can increase half-life, decrease renal clearance, improve stability and reduce aggregation of antibody fragments without compromising their antigen binding. Meanwhile, engineering of antibody fragments can be used to control conjugation to polymers and coupling to responsive polymers can enable intracellular delivery or context responsive release of a drug payload from a polymer–antibody fragment complex. Recent years have seen polymer–antibody fragment conjugates increasingly encroach into areas traditionally associated with monoclonal antibody–polymers and we discuss the potential of such conjugates, in vivo and in vitro, in applications such as drug delivery, tissue engineering, diagnostics and bioseparation.
    No preview · Article · Sep 2013 · Progress in Polymer Science
Show more